Corcept Therapeutics Inc’s filing revealed that its Director Swisher Daniel N JR unloaded Company’s shares for reported $0.11 million on Jan 10 ’25. In the deal valued at $50.54 per share,2,200 shares were sold. As a result of this transaction, Swisher Daniel N JR now holds 0 shares worth roughly $0.0.
Then, Swisher Daniel N JR bought 2,200 shares, generating $111,188 in total proceeds.
Before that, Maduck Sean sold 20,000 shares. Corcept Therapeutics Inc shares valued at $1,007,800 were divested by the insider at a price of $50.39 per share. As a result of the transaction, Maduck Sean now holds 85,318 shares, worth roughly $4.41 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Tuesday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock jump 1.18% to $51.66. Corcept Therapeutics Inc shares have risen nearly 2.52% since the year began. Nevertheless, the stocks have risen 120.30% over the past one year. While a 52-week high of $62.22 was reached on 01/14/25, a 52-week low of $20.84 was recorded on 01/13/25. SMA at 50 days reached $54.62, while 200 days put it at $38.93.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 50.86, which if violated will result in even more drops to 50.06. On the upside, there is a resistance level at 52.51. A further resistance level may holdings at 53.35. The Relative Strength Index (RSI) on the 14-day chart is 46.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.04%. Stochastics %K at 38.79% indicates the stock is a holding.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2024-12-31, dropping by -1.09 million shares to a total of 15.96 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 17.05 million shares. There was a decline of -6.85%, which implies that there is a negative sentiment for the stock.
